We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$114M
AUM Growth
-$23.6M
Cap. Flow
-$8.89M
Cap. Flow %
-7.77%
Top 10 Hldgs %
48.95%
Holding
74
New
18
Increased
7
Reduced
11
Closed
24

Top Buys

Rank Stock Value
1
HNT
HEALTH NET INC
HNT
+$3.16M
2
MRK icon
Merck
MRK
+$2.39M
3
SLTM
SOLTA MED INC (DE)
SLTM
+$2.02M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.95M
5
ANIP icon
ANI Pharmaceuticals
ANIP
+$1.3M

Top Sells

Rank Stock Value
1
ARAY icon
Accuray
ARAY
+$3.89M
2
CAH icon
Cardinal Health
CAH
+$3.3M
3
TECH icon
Bio-Techne
TECH
+$2.76M
4
OFIX icon
Orthofix Medical
OFIX
+$1.92M
5
HUM icon
Humana
HUM
+$1.84M

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.65%
2 Healthcare 43.35%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$81.9B
$8M 6.99%
75,000
-125,000
-63% -$12.9M
ENDP
2
PUT
DELISTED
Endo International plc
ENDP
$6.82M 5.96%
150,000
+50,000
+50% +$2.01M
SUPN icon
3
Supernus Pharmaceuticals
SUPN
$2.57B
$6.35M 5.55%
865,745
+143,431
+20% +$963K
MRK icon
4
CALL
Merck
MRK
$369B
$5.95M 5.2%
131,000
-78,600
-38% -$3.59M
MDY icon
5
PUT
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
$5.66M 4.95%
25,000
– –
ANIP icon
6
ANI Pharmaceuticals
ANIP
$1.69B
$5.41M 4.73%
554,088
+179,977
+48% +$1.3M
AUXL
7
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$5.18M 4.53%
284,481
+10,000
+4% +$181K
AZN icon
8
AstraZeneca
AZN
$255B
$4.27M 3.73%
82,239
– –
SPY icon
9
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$827B
$4.2M 3.67%
25,000
– –
DGX icon
10
Quest Diagnostics
DGX
$27B
$4.15M 3.63%
67,208
– –
TEVA icon
11
CALL
Teva Pharmaceuticals
TEVA
$43.8B
$3.78M 3.3%
100,000
-70,000
-41% -$2.73M
MRK icon
12
Merck
MRK
$369B
$3.19M 2.79%
70,216
+52,400
+294% +$2.39M
HNT
13
DELISTED
HEALTH NET INC
HNT
$3.17M 2.77%
+100,000
New +$3.16M
FRX
14
DELISTED
FOREST LABORATORIES INC
FRX
$3.01M 2.63%
70,382
-15,000
-18% -$652K
LLY icon
15
CALL
Eli Lilly
LLY
$1.05T
$2.52M 2.2%
+50,000
New +$2.62M
LLY icon
16
PUT
Eli Lilly
LLY
$1.05T
$2.52M 2.2%
+50,000
New +$2.62M
GSK icon
17
GSK
GSK
$101B
$2.31M 2.02%
36,773
– –
SUPN icon
18
CALL
Supernus Pharmaceuticals
SUPN
$2.57B
$2.2M 1.92%
300,000
-150,000
-33% -$1.01M
GIVN
19
DELISTED
GIVEN IMAGING LTD
GIVN
$2.11M 1.85%
109,950
– –
IPXL
20
CALL
DELISTED
Impax Laboratories, Inc.
IPXL
$1.98M 1.73%
+96,900
New +$2M
VPHM
21
PUT
DELISTED
VIROPHARMA INC
VPHM
$1.96M 1.72%
+50,000
New +$1.63M
QLTI
22
DELISTED
QLT Inc
QLTI
$1.92M 1.68%
415,139
+50,000
+14% +$217K
TEVA icon
23
Teva Pharmaceuticals
TEVA
$43.8B
$1.89M 1.65%
+50,000
New +$1.95M
CRTX
24
CALL
DELISTED
CORNERSTONE THERAPEUTICS INC
CRTX
$1.88M 1.65%
200,000
-13,100
-6% -$118K
HUM icon
25
Humana
HUM
$47.1B
$1.87M 1.63%
20,000
-20,100
-50% -$1.84M
1
2 3

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Healthcare Value Capital held 74 positions worth $114M, down 17% from $138M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Healthcare Value Capital withdrew a net $8.89M in Q3 2013, closing 24 positions and reducing 11 holdings. Its most notable exit was Accuray, an estimated $3.89M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 60% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Healthcare Value Capital opened a new position in HEALTH NET INC worth $3.17M.

  • Healthcare Value Capital's largest Q3 2013 buy was HEALTH NET INC: 100,000 shares worth $3.17M.
  • Healthcare Value Capital added most to Merck in Q3 2013, an estimated $2.39M increase.
  • Healthcare Value Capital's biggest Q3 2013 reduction was Humana, cutting an estimated $1.84M.
  • Healthcare Value Capital fully exited Accuray in Q3 2013, selling an estimated $3.89M.
  • Healthcare Value Capital's ten largest holdings make up 49% of its $114M portfolio in Q3 2013.
  • Healthcare Value Capital opened 18 new positions and closed 24 in Q3 2013.
  • Healthcare Value Capital's portfolio value fell 17% quarter-over-quarter to $114M.

Based on Healthcare Value Capital's 13F filing for Q3 2013, filed 5 Nov 2013.